The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium

Haemophilia. 2007 Nov;13(6):745-9. doi: 10.1111/j.1365-2516.2007.01542.x. Epub 2007 Sep 10.

Authors

B M Feldman¹, L Aledort, M Bullinger, F M Delaney, A S Doria, S Funk, P Giangrande, B Lundin, M Manco-Johnson, A Miners, P C Scriba, A Srivastava, W Schramm, V S Blanchette; Second International Prophylaxis Study Group

Affiliation

¹ Department of Pediatrics, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada. brian.feldman@sickkids.ca

PMID: 17850325
DOI: 10.1111/j.1365-2516.2007.01542.x

No abstract available

Publication types

Congress
Research Support, Non-U.S. Gov't

MeSH terms

Cost-Benefit Analysis
Health Policy
Hemophilia A / economics*
Hemophilia A / prevention & control*
Hemophilia A / therapy
Humans
Insurance, Health
North America
United Kingdom